Response to the letter by Buldukoglu et al. regarding our manuscript “Body mass index and survival among patients with advanced biliary tract cancer: a single-institutional study with nationwide data-based validation”-Reference-Cited by-同舟云学术

Response to the letter by Buldukoglu et al. regarding our manuscript “Body mass index and survival among patients with advanced biliary tract cancer: a single-institutional study with nationwide data-based validation”

Published:2024-08-06 Issue: Volume: Page:
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Takaoka Shinya,Hamada Tsuyoshi,Nakai Yousuke^ORCID,Yasunaga Hideo,Fujishiro Mitsuhiro

Funder

Ministry of Health, Labour and Welfare

Japan Society for the Promotion of Science

Takeda Science Foundation

Daiichi Sankyo Company

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00535-024-02143-6.pdf

Reference5 articles.

1. Takaoka S, Hamada T, Takahara N, et al. Body mass index and survival among patients with advanced biliary tract cancer: a single-institutional study with nationwide data-based validation. J Gastroenterol. 2024. https://doi.org/10.1007/s00535-024-02124-9.

2. Wijayatunga NN, Dhurandhar EJ. Normal weight obesity and unaddressed cardiometabolic health risk-a narrative review. Int J Obes (Lond). 2021;45:2141–55.

3. Takaoka S, Hamada T, Takahara N, et al. Skeletal muscle status and survival among patients with advanced biliary tract cancer. Int J Clin Oncol. 2024;29:297–308.

4. Gao Q, Hu K, Gao J, et al. Prevalence and prognostic value of sarcopenic obesity in patients with cancer: a systematic review and meta-analysis. Nutrition. 2022;101: 111704.

5. Takeda T, Okamoto T, Sasaki T, et al. The impact of osteosarcopenia in patients with unresectable or recurrent biliary tract cancer receiving palliative chemotherapy. Jpn J Clin Oncol. 2023;53:1051–7.